Related Experiment Videos
Thymidine kinase in megaloblastic anaemia
British Journal of Haematology
|August 1, 1976
Summary
Thymidine kinase levels are elevated in megaloblastic anemia patients, suggesting a role for the salvage pathway in managing DNA synthesis when the de novo pathway fails. This enzyme activity may influence anemia severity.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Megaloblastic anemia is characterized by impaired DNA synthesis.
- Thymidine kinase is a key enzyme in DNA precursor metabolism.
Purpose of the Study:
- To investigate thymidine kinase activity in megaloblastic anemia.
- To explore the impact of folate and vitamin B12 on enzyme levels.
- To understand the enzyme's role in anemia pathogenesis.
Main Methods:
- Measurement of thymidine kinase activity in phytohaemagglutinin-stimulated lymphocytes from normal subjects and patients.
- In vitro addition of folic acid and vitamin B12.
- Inhibition studies with methotrexate and 5-fluorouracil.
Main Results:
- Significantly higher thymidine kinase levels were observed in megaloblastic anemia patients compared to controls.
- Folic acid partially reduced enzyme levels in patients; vitamin B12 had a variable effect.
- Methotrexate and 5-fluorouracil increased thymidine kinase activity in normal lymphocytes, indicating enzyme induction.
- Thymidine mono- and di-phosphate kinase activities were higher than thymidine kinase and unaffected by methotrexate.
Conclusions:
- Elevated thymidine kinase in megaloblastic anemia suggests compensatory upregulation of the salvage pathway.
- Enzyme activity may correlate with the severity of anemia.
- Inhibition of de novo synthesis induces thymidine kinase, highlighting its regulatory role.